Altana (NYSE:AAA)
Historical Stock Chart
From May 2019 to May 2024
ALTANA Inc Inaugurates 100,000 sq. ft. of Manufacturing Space in
Hicksville, New York
- Leading Pharmaceutical Manufacturer Cites Growth and Increased Demand for
Topical Drugs Behind Expansion -
HICKSVILLE, N.Y., May 12 /PRNewswire/ -- ALTANA Inc, a division of ALTANA
Pharma AG, today formally inaugurated a 100,000-sq. ft. state-of-the-art
manufacturing plant in Hicksville, New York, on Long Island. Elected officials,
including New York State Senator Carl L. Marcellino (R-Syosset), joined company
executives, employees and customers at a ribbon-cutting ceremony where the
plant was officially opened for business.
The plant will primarily be utilized by ALTANA's Fougera division for the
production of a wide range of topical multisource antibiotics, ophthalmics and
steroids covering a number of prescription applications. Certain products
under ALTANA's PharmaDerm division will also be produced there. "Our core
business is manufacturing topical drugs which save American consumers millions
of dollars each year and help reduce or contain rising health care costs," said
CEO Paul McGarty, who oversees ALTANA Inc. "Our robust product pipeline, which
continues to give us a leadership position, necessitated the expansion of our
Hicksville operation."
Incorporating a 43,000-sq. ft. addition, the upgraded facility at 55 Cantiague
Rock Road represents a near doubling of the company's manufacturing capability
in Hicksville, where it employs 150 Long Islanders. An additional 350 people
are employed at ALTANA's Melville, New York, headquarters location.
In 2004, over 1.3 million kilos of bulk product, equating to nearly 50 million
units, were produced at the Hicksville plant. With the upgrades, the facility
now has an additional 30-40% production capacity, which will support the
company's sustained growth in the future.
The expanded facility, which is fully compliant with FDA-enforced Good
Manufacturing Practices (GMP), significantly improves material flows to and
from the production line and provides enhanced operating efficiencies. The
additional space also enabled the installation of new automated equipment.
ALTANA Inc was commended by local officials for its commitment to maintaining
and growing its operations in New York State.
"ALTANA's commitment to expand its facility in Hicksville is welcome news for
the community and will provide a strong measure of stability in the future for
the local economy," Senator Carl L. Marcellino said. "Retaining and creating
new jobs is vital to our continued economic growth and ALTANA Inc is playing a
major role in fueling the economic development of Hicksville and all of Long
Island."
"We have enjoyed a long and proud record of success over 156 years of operation
in New York State. Long Island is our home, and we have prospered thanks to the
highly skilled and dedicated workforce we employ here," said Helen Corso, Vice
President of Manufacturing. "The expansion is also consistent with our
commitment to ongoing capital expenditure on property, plants and equipment to
meet increased demand for topical pharmaceuticals."
About Fougera
Founded in 1849 Fougera, a division of ALTANA Inc, is a leading manufacturer of
a wide array of multi-source topical and ophthalmic pharmaceuticals in
prescription and over-the-counter forms. A top supplier to hospitals and
pharmacies, Fougera has received more FDA approvals for topical products than
any other company over the past six years. For more information, or to see a
preview of new products, please visit: http://www.fougera.com/.
About ALTANA Inc
ALTANA Inc, one of two U.S. subsidiaries of ALTANA Pharma AG, an international
pharmaceutical company headquartered in Germany, is the managing group for four
New York-based divisions including: Fougera and PharmaDerm, which produce
topical dermatologic ointments and creams; Pharmaderm Animal Health, a
manufacturer of topical preparations for animal care and Savage Laboratories,
marketers of the antidotes CroFab(TM) and DigiFab(R) for hospital emergency
medicine departments.
About ALTANA Pharma AG
ALTANA Pharma AG is the pharmaceutical division of ALTANA AG (NYSE:AAANYSE:
FSE:NYSE:ALT), headquartered in Konstanz, Germany. The international
pharmaceutical group employs more than 8,200 people in over 30 subsidiaries and
is present in markets in Europe, North and South America, Asia, South Africa
and Australia. In 2004, the company achieved sales of about 2.1 billion euro,
up 7% from 2003. ALTANA Pharma concentrates on innovative pharmaceutical
products in therapeutics, imaging (contrast media) and OTC medication.
Therapeutics, the most important business area, is based on prescription drugs
for gastrointestinal and respiratory diseases. Research focuses on
gastroenterology, respiratory/inflammation and oncology.
DATASOURCE: ALTANA Inc
CONTACT: Don Miller of HLDBlankman Public Relations, +1-516-536-6811,
or +1-212-896-3926, , for ALTANA Inc
Web site: http://www.fougera.com/